Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Matsui, Reiko | Person |
Why?
|
| Glutaredoxin-1 Deficiency Causes Fatty Liver and Dyslipidemia by Inhibiting Sirtuin-1. | Academic Article |
Why?
|
| Glutathionylation of the Active Site Cysteines of Peroxiredoxin 2 and Recycling by Glutaredoxin. | Academic Article |
Why?
|
| IL-33 induction and signaling are controlled by glutaredoxin-1 in mouse macrophages. | Academic Article |
Why?
|
| Redox Regulation via Glutaredoxin-1 and Protein S-Glutathionylation. | Academic Article |
Why?
|
| Role of Glutaredoxin-1 and Glutathionylation in Cardiovascular Diseases. | Academic Article |
Why?
|
| Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson''s Disease. | Academic Article |
Why?
|
| Glutaredoxins | Concept |
Why?
|
| Administration of Glutaredoxin-1 Attenuates Liver Fibrosis Caused by Aging and Non-Alcoholic Steatohepatitis. | Academic Article |
Why?
|
| Glutaredoxin-1 regulates hepatic lipid metabolism impacting atherogenesis | Grant |
Why?
|
| Regulation of Hypoxia-incucable factor-1 and angiogenesis by glutaredoxin-1 | Grant |
Why?
|
| Regulation of ischemic limb vascularization by glutaredoxin-1 | Grant |
Why?
|
| Role of glutaredoxin-1 in endothelial barrier dysfunction and atherosclerosis | Award or Honor Receipt |
Why?
|
| Attenuated cardiovascular hypertrophy and oxidant generation in response to angiotensin II infusion in glutaredoxin-1 knockout mice. | Academic Article |
Why?
|
| Glutaredoxin-1 up-regulation induces soluble vascular endothelial growth factor receptor 1, attenuating post-ischemia limb revascularization. | Academic Article |
Why?
|